Quality of life and well-being of patients with myasthenia gravis
- PMID: 11268023
- DOI: 10.1002/mus.1034
Quality of life and well-being of patients with myasthenia gravis
Abstract
The cardinal symptom of myasthenia gravis (MG) is weakness of voluntary muscles, a feature that may restrict full participation in life activities. In turn, such limitations may negatively affect quality of life (QOL) and well-being among individuals with the disease. In the present study, we administered a measure of QOL to 27 patients with generalized MG. Results revealed that functional status was negatively impacted in the domains of physical functioning, energy, and general health. However, a clinically meaningful difference was evident only on perceived ability to accomplish physical tasks. The results suggest that although MG requires accommodations in physical activities, general QOL and well-being does not differ markedly from the general population.
Copyright 2001 John Wiley & Sons, Inc.
Comment in
-
Quality of life in patients with myasthenia gravis.Muscle Nerve. 2002 Mar;25(3):466-7. doi: 10.1002/mus.10035. Muscle Nerve. 2002. PMID: 11870729 No abstract available.
Similar articles
-
Severity of mood, self-evaluative, and vegetative symptoms of depression in myasthenia gravis.J Neuropsychiatry Clin Neurosci. 2000 Fall;12(4):499-501. doi: 10.1176/jnp.12.4.499. J Neuropsychiatry Clin Neurosci. 2000. PMID: 11083168
-
Disease-specific measure of quality of life for myasthenia gravis.Muscle Nerve. 2008 Aug;38(2):947-56. doi: 10.1002/mus.21016. Muscle Nerve. 2008. PMID: 18697209
-
Quality of life in 188 patients with myasthenia gravis in China.Int J Neurosci. 2016;126(5):455-62. doi: 10.3109/00207454.2015.1038712. Epub 2015 Jun 5. Int J Neurosci. 2016. PMID: 26000922
-
Pediatric Myasthenia Gravis.Semin Pediatr Neurol. 2017 May;24(2):116-121. doi: 10.1016/j.spen.2017.04.003. Epub 2017 Apr 7. Semin Pediatr Neurol. 2017. PMID: 28941526 Review.
-
Drug-induced neuromuscular blockade and myasthenia gravis.Pharmacotherapy. 1997 Nov-Dec;17(6):1220-32. Pharmacotherapy. 1997. PMID: 9399604 Review.
Cited by
-
Understanding side effects of therapy for myasthenia gravis and their impact on daily life.BMC Neurol. 2019 Dec 21;19(1):335. doi: 10.1186/s12883-019-1573-2. BMC Neurol. 2019. PMID: 31864345 Free PMC article.
-
Determinants of Quality of Life in Myasthenia Gravis Patients.Front Neurol. 2020 Sep 23;11:553626. doi: 10.3389/fneur.2020.553626. eCollection 2020. Front Neurol. 2020. PMID: 33071942 Free PMC article.
-
The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study.J Neurol. 2010 Jan;257(1):98-102. doi: 10.1007/s00415-009-5279-z. Epub 2009 Aug 8. J Neurol. 2010. PMID: 19669388
-
Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study.BMJ Open. 2017 Feb 23;7(2):e013278. doi: 10.1136/bmjopen-2016-013278. BMJ Open. 2017. PMID: 28235967 Free PMC article.
-
Marathons and myasthenia gravis: a case report.BMC Neurol. 2018 Sep 18;18(1):145. doi: 10.1186/s12883-018-1150-0. BMC Neurol. 2018. PMID: 30227849 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical